Peak Ridge Capital

Peak Ridge Capital is a global alternative asset management firm founded in 2000 and headquartered in Boston, Massachusetts, with additional offices in Madison, Wisconsin, Calgary, Canada, and Hamilton, Bermuda. The firm specializes in private equity and venture capital, focusing on growth capital investments across various sectors, including agriculture, real estate, and energy in the United States. It aims to provide unique investment products tailored to the specific expectations and objectives of its diverse investor base. In addition to its equity investments, Peak Ridge Capital manages hedge funds that invest in commodities markets, employing quantitative models and arbitrage trading strategies. The firm also seeks to co-invest in its portfolio companies, thereby enhancing value for its investors.

Daniel Greene

Partner

Jason Rome

Operating Partner

Jason Smith

President and Private Equity Partner

9 past transactions

Rapid Diagnostek

Series B in 2010
Rapid Diagnostek formerly Intellignostics, has developed a patented, inexpensive, easy to use sensor appropriate for detecting bacteria, viruses, spores and disease biomarkers. Markets of opportunity include human and veterinary diagnostic, environmental, biohazard, bioterrorism, agricultural commodity, and food safety testing. Its technology offers remarkably faster and less expensive results than existing methods. Current diagnostic tests can take hours to days from the time a sample is taken to delivery of results. Rapid Diagnostek's IntelliProbe Immunosensor (IPI) platform can deliver results at the point of sampling in under 60 seconds. The sensor has performed as intended in the laboratory and the company is now developing a fully functioning device and initial assays to aggressively move towards commercialization.

Xolve

Funding Round in 2012
Xolve, Inc., a nanomaterials company, produces and supplies graphene that is used to improve the properties of various industrial plastics for use in automotive, aerospace, electronics, and other applications. It offers graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene. Xolve, Inc. was formerly known as Graphene Solutions, Inc. and changed its name to Xolve, Inc. in September 2010. The company was founded in 2008 and is based in Middleton, Wisconsin. As of March 31, 2016, Xolve, Inc. operates as a subsidiary of Reliance Industries Limited.

Zurex Pharma

Series B in 2014
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Zurex Pharma

Seed Round in 2011
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Rapid Diagnostek

Series A in 2008
Rapid Diagnostek formerly Intellignostics, has developed a patented, inexpensive, easy to use sensor appropriate for detecting bacteria, viruses, spores and disease biomarkers. Markets of opportunity include human and veterinary diagnostic, environmental, biohazard, bioterrorism, agricultural commodity, and food safety testing. Its technology offers remarkably faster and less expensive results than existing methods. Current diagnostic tests can take hours to days from the time a sample is taken to delivery of results. Rapid Diagnostek's IntelliProbe Immunosensor (IPI) platform can deliver results at the point of sampling in under 60 seconds. The sensor has performed as intended in the laboratory and the company is now developing a fully functioning device and initial assays to aggressively move towards commercialization.

Zurex Pharma, Inc.

Private Placement in 2018
Zurex Pharma, Inc., a pharma and medical technology company, develops and commercializes antimicrobial products to prevent health care-associated infections on surgical site wounds and catheter-related infections. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of surgical site infections; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound. The company was incorporated in 2008 and is based in Middleton, Wisconsin. Zurex Pharma, Inc. operates as a subsidiary of Ash Access Technology, Inc.

Forest at Chasewood Apartments

Merger/Acquisition in 2016
220-unit Beacon Eastchase comprises a 220 unit apartment community. The property is located in Charlotte, North Carolina.

Zurex Pharma

Series D in 2018
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Zurex Pharma

Series A in 2012
Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.